Countries Australia
BioFactura Announces Initiation of Phase I Study of BFI-751, a Stelara® Biosimilar
First clinical trial from BioFactura’s pipeline of high-value biosimilar and biodefense drugs BFI-751: Biosimilar designed to treat people with Cr...
June 01, 2021 | News
World-first multiple sclerosis global image database launched
A world-first global MS image database launched in Australia today complementing MSBase, the largest clinical MS patient registry, to advance MS research w...
May 31, 2021 | News
Avance Clinical Releases Industry Survey Results at BIO Korea 2021
The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award recipient Avance Clinical shared results of a rec...
May 27, 2021 | News
Multiply Labs Joins forces with Cytiva to automate cell therapy manufacturing.
Creating a fully automated robotic system will bring industrial scale reliability to cell therapy manufacturing while providing speed and flexibi...
May 26, 2021 | News
Top 3 COVID-19 vaccine questions : Vaccine choice, appointments and blood clots
Intended audience: General public Top 3 questions Why can’t I decide which vac...
May 25, 2021 | Opinion
Thermo Fisher Scientific Accelerates Complex Materials Research at Monash University
The Thermo Scientific Spectra φ is configured to provide enhanced electron beam flexibility to optimize advanced imaging of complex material systems. T...
May 24, 2021 | News
Agilex Biolabs Partners with Endpoints News for Clinical Trials
Agilex Biolabs' Director, Immunoassay, Kurt J. Sales (B.Sc; B.Sc (MED) Hons; M.Sc, Ph.D, PGCM) said:"Inflammation is a complex biological process involving...
May 21, 2021 | News
Phebra's Confirm Bioequivalence of Oral and IV Formulations
Australian pharmaceutical group Phebra ('Company') congratulates the Australasian Leukaemia and Lymphoma Group (ALLG) on the release of their abstract EP43...
May 14, 2021 | News
Australia Secures Moderna Vaccines
As confirmed in the 2021-22 Budget, the Government will commence an approach to market for mRNA manufacturing capacity in Australia. The Government also r...
May 13, 2021 | News
Most Read
- Lack of Regular Screening Fuels Rise in Late-Stage Breast Cancer in Hong Kong, New Report Reveals
- BIOCHINA 2025: Connecting Global Innovators with China's Leading Biotech Firms
- Leon Wyszkowski, President of Analytical Services, Discusses Thermo Fisher's Strategic Move: Expanding Bioanalytical Capabilities in Europe with New Sweden Lab
- The Role of Policy and Public Health Initiatives in Addressing Women's Cancer Care in Asia
- Redefining Patient Safety in the Age of Healthtech
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
